ArticleFrontiers in neurology

Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis.

Sabrina M Stollberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.